AK-123

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAK-123
Drug Alias NameAK-123AK123
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockers5'-nucleotidase inhibitors
TargetsProgrammed cell death protein 15'-nucleotidase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhongshan Akeso Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongshan Akeso Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A